Abstract: An anti-osteopathic composition comprising as an active ingredient a compound represented by the following formula (I), (II) or (III): ##STR1## which is useful for therapeutic and prophylactic treatment of osteopathia such as osteoporosis and bone fracture.

Abstract: Treatment of osteopathic comprising administering as an active ingredient a compound represented by the following formula (I), (II) or (III): ##STR1##

Abstract: Pharmaceutical compositions for the inhibition of bone resorption comprising a pharmaceutical carrier and a therapeutically effective amount of a benzopyran derivative represented by the general formula (I) ##STR1## wherein the broken-lined bond denotes an optional double bond, R.sub.1 denotes a hydrogen atom or a hydroxyl group, R.sub.2 denotes a cyano group, a phenylsulfonyl group or a halogen-substituted methoxyl group, and R.sub.3 denotes a group having the formula ##STR2## Since they inhibit bone resorption, they are useful for the treatment and prevention of diseases associated with bone metabolism.

Abstract: A compound represented by the following general formula: ##STR1## wherein R.sub.1 and R.sub.2 are the same or different, and represent a hydrogen or halogen, and ring-opened free acid, amides and salts thereof are provided. The present invention also provides a process for the production of the above-mentioned compound starting from the known compound ML-236B.

Abstract: Novel quinoline sulfonamino derivatives having a vessel smooth muscle relaxation activity as well as a platelet agglutination inhibitory activity and inhibitory activity to protein kinase A, myosin light chain kinase, proteinkinase C, and calmodulindependent proteinkinase II, but having little action or cardio function; a process for the production of the derivatives, and a pharmaceutical composition containing the derivative.

Abstract: Novel quinoline sulfonamino derivatives having a vessel smooth muscle relaxation activity as well as a platelet agglutination inhibitory activity and inhibitory activity to protein kinase A, myosin light chain kinase, proteinkinase C, and calmodulindependent proteinkinase II, but having little action or cardio function; a process for the production of the derivatives, and a pharmaceutical composition containing the derivative.

Abstract: Novel quinoline sulfonamino derivatives having a vessel smooth muscle relaxation activity as well as a platelet agglutination inhibitory activity and inhibitory activity to protein kinase A, myosin light chain kinase, proteinkinase C, and calmodulindependent proteinkinase II, but having little action or cardio function; a process for the production of the derivatives, and a pharmaceutical composition containing the derivative.

Abstract: Novel compounds represented by the formula: ##STR1## wherein R.sub.1 represents an alkyl group having 1 to 3 carbon atoms, R.sub.2 represents an amino group or a group of formula ##STR2## in which R.sub.4 represents an alkyl group having 1 to 3 carbon atoms, R.sub.5 represents an alkyl group having 1 to 3 carbon atoms or may combine with R.sub.6 to form a five or six membered ring containing 4 to 5 carbon atoms, R.sub.6 represents a hydrogen atom or may combine with R.sub.5 to form a five or six membered ring containing 4 to 5 carbon atoms, R.sub.3 represents a hydrogen atom, an alkyl group having 1 to 3 carbon atoms or a halogen atom, X represents a carbonyl group or a methylene group, Y represents a sulfur atom or a vinylene group and pharmaceutically acceptable salts thereof which exhibit a vasodilating activity and inhibitory activity for platelet aggregation. Thus, they are useful as therapeutic agents for treatment of angina pectoris, hypertension, throbosis and the like.

Abstract: This invention provides a blood typing training kit comprising a red blood cell model and an antiserum model with no use of human blood in experiments for blood agglutination and in learning of blood typing, the red blood cell model being an easily available granule which can be suspended in water such as agarose bead, Sepharose, cellulose, Sephadex, cellulofine, alginate, tamarind polysaccharide, gelatin, xanthan gum, etc. or the saccharide- or protein-bound form thereof and the antiserum model being lectin, boric acid-containing liquid or immunoglobulin G.

Abstract: A control device adapted for remotely controlling a plurality of moving appendages or functions of a toy or a small machine, is disclosed. The toy includes a drive motor which provides power to rotate a drive gear. A control gear is pivotably mounted within the toy. It is permanently meshed with the drive gear and is laterally displaceable relative thereto. A plurality of output gears are mounted in the toy in positions wherein the control gear is capable of selectively meshing with each output gear dependent upon the positioning of the control gear relative to the drive gear. Each output gear drives a different appendage or function of the toy. A control motor which is actuable at the option of a player through a suitable remote control device, is provided in the toy. The control motor rotates a cam which laterally moves a cam follower connecting piece.

Abstract: The present invention is directed to a mobile toy assembly capable of ejecting toy subcomponents by air pressure. Preferably the mobile toy assembly has a simulated configuration of a rocket ship with an upper portion being simulated as a fuselage while also being the external surface of a plunger that forms part of a bellows assembly for generating air pressure. The nose section of the rocket ship can be bigurcated to permit the propulsion of a small vehicle member while rocket pods on each of the side wings can support toy rocket projectiles. A control knob on the surface of the fuselage can selectively direct the air pressure to a particular toy subcomponent to be propelled.

Abstract: A toy assembly capable of maintaining a toy figure in a floating position within a transparent container, is disclosed. A base member attached to the container includes a first permanent magnet. A floating base member dimensioned to be slideably contained within the container includes a second permanent magnet. The toy figure is removably mounted on the floating base member. The first and second magnets are disposed to repel each other thereby causing the toy figure to float within the container. A plurality of toy appendages are provided. These include a carriage member upon which the floating base member may be mounted together with the toy figure. The first permanent magnet may be used to propel the assembly of the carriage member, the floating base member and the toy figure on a support surface.